Other studies have found that IL-17F, but not IL-17A, underlies airway inflammation in steroid-insensitive toluene diisocyanate-induced asthma models and that anti-IL-17F ameliorates toluene diisocyanate-induced AHR and airway neutrophilia with a reduced Th17 response (117). Here, IL17F is linked to asthma.